Biomedica—an established EU-based company with offices in the EU, USA, CEE, CIS, Turkey, and Israel—delivers a fully integrated value chain. We manage all aspects of commercialization directly, utilizing our own experienced local teams for market access, regulatory affairs, distribution, pharmacovigilance, compliance, and government relations. We do not rely on intermediaries, ensuring speed, accountability, and consistent quality throughout the launch process.

Since 2019, we have successfully launched over 10 innovative orphan products in our regions, with first sales achieved within 6–8 months of contract signing. This proven track record allows your team to remain focused on core US/EU launches while we handle all the heavy lifting in our territories.

For even broader coverage, our exclusive partnership with a leading Swiss pharmaceutical distributor enables rapid, compliant access in nearly all regions outside the US/EU.